Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimodivir + SOC in Non-hospitalized Influenza A
NCT03381196Phase 3Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 38
01
Overview
A Phase 3 trial of pimodivir in Influenza A (IAV), sponsored by Janssen Pharmaceutical. Started Jan 2018; status: terminated.
02
Drugs
pimodivir
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT03381196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03381196.